Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Emerson Radio Extends Licensing Deal With Funai - Quick Facts

Emerson Radio Corp. (MSN: Quote) announced that On December 17, 2012, and effective as of December 1, 2012, Emerson and Funai Corporation Inc. entered into an amendment to the License Agreement dated effective January 1, 2001, as amended, between the Company and Funai, under which the term of the License Agreement was extended until March 31, 2015.

The Agreement provides that Funai will continue to manufacture, market, sell and distribute specified products bearing the Emerson trademark to customers in the U.S. and Canadian markets.

As per the terms of the License Agreement, Emerson Radio receives non-refundable minimum annual royalty payments of $3.75 million each calendar year ($937,500 per calendar quarter) and license fees on sales of products subject to the License Agreement in excess of the minimum annual royalties.

Click here to receive FREE breaking news email alerts for Emerson Radio Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.